Updating results

784 results for end of life care Sort: Relevance | Date

End of life care

All NICE products on End of life care. Includes any guidance, NICE Pathways and quality standards.

End of life care for people with life-limiting conditions

Everything NICE has said about the care of people with a progressive life-limiting condition who are at the end of their life in an interactive flowchart

NICE Pathway Published March 2017 Last updated September 2017

End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)

Evidence-based recommendations on managment of end of life care for infants, children and young people (aged 0–17 years) with life-limiting conditions

NICE guideline Published December 2016

Palliative care for adults: strong opioids for pain relief (CG140)

Evidence-based recommendations on strong opioids for pain relief for adults having palliative (end of life) care

Clinical guideline Published May 2012 Last updated August 2016

Care of dying adults in the last days of life (NG31)

Evidence-based recommendations on the clinical care of dying adults at the very end of life

NICE guideline Published December 2015

End of life care for adults in the last year of life: service delivery

In development [GID-CGWAVE0799] Expected publication date: 18 July 2018

NICE guideline In development

Networked approach to implementing NG61 (End of life care for infants, children & young people)

Shared learning Published January 2018 Last updated February 2018

The diagnosis of levels of distress for end of life residents in care homes

Shared learning Published October 2014 Last updated April 2015

Care and support of people growing older with learning disabilities (NG96)

Evidence-based recommendations on care and support for adults with learning disabilities as they grow older

NICE guideline Published April 2018

Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation (CG135)

Evidence-based recommendations on identifying potential organ donors and obtaining consent for deceased organ donation for transplantation

Clinical guideline Published December 2011 Last updated December 2016

Motor neurone disease: assessment and management (NG42)

Evidence-based recommendations for assessing and managing motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS).

NICE guideline Published February 2016

Transition between inpatient hospital settings and community or care home settings for adults with social care needs (NG27)

Evidence-based recommendations on the transition between inpatient hospital settings and community or care homes for adults with social care needs.

NICE guideline Published December 2015

Motor neurone disease

Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart

NICE Pathway Published November 2013 Last updated June 2018

Care of dying adults in the last days of life (QS144)

Evidence-based statements to deliver quality improvements in the care of dying adults (aged 18 and over) in the last 2 to 3 days of life

Quality standard Published March 2017

Myeloma: diagnosis and management (NG35)

Evidence-based recommendations on the diagnosing and managing of myeloma in people aged 16 and over.

NICE guideline Published February 2016

Idiopathic pulmonary fibrosis in adults: diagnosis and management (CG163)

Evidence-based recommendations on diagnosing and managing idiopathic pulmonary fibrosis (IPF) (hardening of the lungs) in adults

Clinical guideline Published June 2013 Last updated May 2017

Endocrine cancers

Everything NICE has said on endocrine cancers in an interactive flowchart

NICE Pathway Published March 2018 Last updated April 2018

People's experience in adult social care services: improving the experience of care and support for people using adult social care services (NG86)

Evidence-based recommendations on the care and support of adults receiving social care in their own homes, residential care and community settings

NICE guideline Published February 2018

Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease (TA449)

Evidence-based recommendations on everolimus (Afinitor) and sunitinib (Sutent) for treating neuroendocrine tumours in adults

Technology appraisal guidance Published June 2017

Crohn's disease: management (CG152)

Evidence-based recommendations on managing Crohn's disease in adults, young people and children

Clinical guideline Published October 2012 Last updated May 2016

Osteoarthritis

Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart

NICE Pathway Published February 2014 Last updated November 2017

Preventing falls in older people

Everything NICE has said on assessing and preventing falls in older people in the community and in hospital, in an interactive flowchart

NICE Pathway Published June 2013 Last updated September 2017

Cirrhosis in over 16s: assessment and management (NG50)

Evidence-based recommendations on diagnosing and managing cirrhosis (scarring of the liver) in over 16s

NICE guideline Published July 2016

Emergency and acute medical care in over 16s: service delivery and organisation

Everything NICE has said on service delivery and organisation for emergency and acute medical care in over 16s in an interactive flowchart

NICE Pathway Published March 2018

Surgical site infections: prevention and treatment (CG74)

Evidence-based recommendations on preventing and treating surgical site infections for adults, young people and children who are having a surgical procedure

Clinical guideline Published October 2008 Last updated February 2017

Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia (TA451)

Evidence-based recommendations on ponatinib (Iclusig) for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia in adults

Technology appraisal guidance Published June 2017

Bladder cancer

Everything NICE has said on bladder cancer in adults in an interactive flowchart

NICE Pathway Published December 2015 Last updated June 2018

Idiopathic pulmonary fibrosis

Everything NICE has said on diagnosing and managing suspected idiopathic pulmonary fibrosis in adults in an interactive flowchart

NICE Pathway Published June 2013 Last updated March 2018

Everolimus for advanced renal cell carcinoma after previous treatment (TA432)

Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma (kidney cancer) after previous treatment

Technology appraisal guidance Published February 2017

Intermediate care including reablement (NG74)

Evidence-based recommendations on referral and assessment for intermediate care and how to deliver the service for people at risk of hospital admission or who

NICE guideline Published September 2017

Older people with social care needs and multiple long-term conditions (NG22)

Evidence-based recommendations on the planning and delivery of social care and support for older people who have multiple long-term conditions.

NICE guideline Published November 2015

Cabozantinib for treating medullary thyroid cancer (TA516)

Evidence-based recommendations on cabozantinib (Cometriq) for treating medullary thyroid cancer (MTC) in adults

Technology appraisal guidance Published March 2018

Mental wellbeing and independence in older people

Everything NICE has said on promoting mental wellbeing and independence in older people over 65 in an interactive flowchart

NICE Pathway Published November 2012 Last updated December 2016

Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer (TA509)

Evidence-based recommendations on pertuzumab (Perjeta) for HER2-positive, locally recurrent or metastatic (secondary) breast cancer in adults

Technology appraisal guidance Published March 2018

Intermediate care including reablement

Everything NICE has said on referral and assessment for and delivery of intermediate care including reablement in an interactive flowchart

NICE Pathway Published September 2017

Sorafenib for treating advanced hepatocellular carcinoma (TA474)

Evidence-based recommendations on sorafenib (Nexavar) for treating advanced hepatocellular carcinoma (liver cancer) in adults

Technology appraisal guidance Published September 2017

Delirium

Everything NICE has said on preventing and managing delirium in adults presenting to hospital or in long-term care in an interactive flowchart

NICE Pathway Published September 2012 Last updated June 2018

Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment (TA333)

Evidence-based recommendations on axitinib (Inlyta) for treating advanced renal cell carcinoma (RCC) (kidney cancer) when prior systemic treatment has failed

Technology appraisal guidance Published February 2015